Authors
Latest:
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT CareTia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Latest:
Caring for an Immunocompromised Bone Marrow Transplant RecipientSpecial protocols are required to ensure the safety of patients undergoing bone marrow transplants.
Latest:
Questions of Accessibility and Inclusion Continue to Draw Attention in Oncology NursingNo system can properly flourish without constant efforts to diversify, and the nursing field is no exception.
Latest:
Older Patients Are Comfortable With Telehealth and Prefer It as an Option92% of those over 70 say they are comfortable with telehealth.
Latest:
Heather Niccum Haag on Improving Patient Education With BelzutifanHeather Niccum Haag, BSN, RN, CCRN, shares her experience creating an educational resource for her patients with Von-Hippel Lindau tumors who are receiving belzutifan.
Latest:
Advanced Practice Providers Are Uniquely Suited for Survivorship CareAdvanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Latest:
Global Study Suggests More Informational Resources Needed for Renal Cell CarcinomaA global study revealed that patients and caregivers alike reported insufficient knowledge surrounding renal cell carcinoma.
Latest:
Prescribing 20 mg of Mozart for Chemotherapy-Induced NauseaA Michigan State University investigator is preparing to expand on an encouraging pilot study that used a music-listening intervention to influence chemotherapy-induced nausea.
Latest:
5 Media Tips and Tricks For Health Care ProfessionalsHeather Simonsen, MA, outlines some ways for health care professionals to feel more comfortable in the spotlight.
Latest:
Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.
Latest:
Datopotamab Deruxtecan Demonstrates Manageable Safety Profile in TNBCCompared with other antibody-drug conjugates, datopotamab deruxtecan was associated with lower rates of neutropenia, pneumonitis, and hematologic toxicity.
Latest:
Talking With Patients About Potential Cancer MisinformationOncology nurses can help their patients navigate misinformation that they may find online.
Latest:
Top Executives Vow to Improve Health Disparities among Patients with Multiple MyelomaOncology nurses are often the main point of contact for newly diagnosed patients with cancer. We have the opportunity to ensure that each person starts their journey with equality and equity on their side.
Latest:
Chemotherapy Plus Endocrine Therapy Increases Cognitive Impairment in Breast CancerPatients with breast cancer may be at risk for more intense cognitive impairment following treatment with chemotherapy plus endocrine therapy.
Latest:
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing RadiationHilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Latest:
Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival TimesPatients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.
Latest:
Karmanos nurse wins MDONS Outstanding Oncology Nurse of the Year AwardAgnes Pilecki, BSN, RN, a nurse on Barbara Ann Karmanos Cancer Institute’s bone marrow transplant unit, has been named the Metro Detroit Oncology Nursing Society’s (MDONS) Outstanding Oncology Nurse of the Year.
Latest:
Approach Health Disparities From All AnglesApril is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.
Latest:
Reanne Booker on Factors to Consider When Discussing Palliative RadiationReanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.
Latest:
Care Management Tools Can Mitigate Clinician BurnoutAlthough technology alone can’t solve clinician burnout, it can provide the means for organizations to provide better care while increasing efficiency and alleviating stress.
Latest:
Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian CancerPaula Anastasia, RN, MN, AOCN, highlights circumstances in which patients may not be eligible to receive benefit with a PARP inhibitor.
Latest:
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC SubgroupsFindings from the PACIFIC-R trial showed that patients with EGFR-mutated non-small cell lung cancer experienced shorter progression-free survival with durvalumab than patients with EGFR-wildtype disease.
Latest:
First-Line Immunotherapy Is Associated With Worse Survival Outcomes in Synchronous mRCCPatients with synchronous metastatic renal cell carcinoma experienced worse outcomes with first line immune-checkpoint inhibitors-based combinations vs those with metachronous disease.
Latest:
Aliènne Salleroli on Starting the DEI Conversation in Oncology NursingAliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.
Latest:
Michelle Mollica on Individualizing Care Plans for Cancer SurvivorsMichelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.
Latest:
Bring A Nuanced Approach to Venous Thromboembolism ManagementUnderstanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Latest:
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast CancerKara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Latest:
Elizabeth Aronson Breaks Down Data From Behind Talquetamab Approval in Multiple MyelomaElizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MonumenTAL-1 study assessing talquetamab in multiple myeloma.
Latest:
Five Researchers Awarded Pilot Project FundingEvery year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty.
